MELOXICAM (MOVALIS) IN NEUROLOGY: BACK PAIN


Cite item

Full Text

Abstract

The article presents data on the prevalence of one of the most common pain syndromes - back pain. The literary data on the mechanisms of formation of pain and ways to its elimination are proposed. The results of own authors research of use of one of the most popular cyclooxygenase-2 inhibitors - Movalis (meloxicam) - in 767 patients are represented. The results showed fairly stable positive effect of therapy, which led to a decrease in frequency, intensity and duration of acute back pain within two years of follow-up. The possibility of central action of the drug through the effect on «pain» memory is discussed.

References

  1. Павленко С.С. Эпидемиология боли // Неврологический журнал 1999. Т. 4. № 1. С. 41-6.
  2. Crombie IK, Croft PR, et al. Epidemiology of pain. IASP Press, 1999:321.
  3. Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001;334:363-70.
  4. Henry D, Lim LL-Y, Rodriguez LAG, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-66.
  5. Wiesel SW, Tsourmas N, Feffer HL, et al. A study of computer-assisted tomography. I. The incidence of positive CAT scans in asymptomatic groupe of patients. Spine 1984;9:549-51.
  6. Cohen ML. Acute low back pain. In Macintyre PE, Walker SM, Rowbotham DJ. Acute Pain. 2nd ed. Hodder 2008:444-59.
  7. Насонова В.А. Значение циклооксигеназы-2 в развитии боли // Терапевтический архив 2001. № 5. С. 56-7.
  8. Telleria-Diaz A, Neubert AK, Schache F, et al. Different Effects of Spinally Applied COX-1, COX-2, and Nonselective Cyclooxygenase Inhibitors on Inflammation-Evoked Spinal Hyperexcitability. Proceedings of the 11th Wold Congress on Pain, IASP Press 2006:179-86.
  9. Богачева Л.А., Снеткова Е.П. Дорсалгии: классификация, механизмы патогенеза, принципы ведения (опыт работы специализированного отделения боли) // Неврологический журнал 1996. № 2. С. 8-12.
  10. Попелянский Я.Ю. Ортопедическая неврология. Казань, 1997. Т. 2. 487 с.
  11. Хабиров Ф.А. Клиническая неврология позвоночника. Казань, 2002. 472 с.
  12. Иваничев Г.А. Мануальная терапия. М., 1998. 470 с.
  13. Эрдес Ш.Ф. Неспецифическая боль в нижней части спины. Диагностика, лечение, предупреждение. Клинические рекомендации. 2008. 70 с.
  14. Henry D, Lim L L-Y, Rodriguez LAG, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-66.
  15. Насонов Е.Л. Нестероидные противовоспалительные препараты: проблемы безопасности лечения // Consilium medicum 1999. Т. 1. № 5. С. 207-11.
  16. Carr DB, Goudas LC. Acute pain. Lancet 1999;353:2051-58.
  17. Telleria-Diaz A, Neubert AK, Schache F, et al. Different Effects of Spinally Applied COX-1, COX-2, and Nonselective Cyclooxygenase Inhibitors on Inflammation-Evoked Spinal Hyperexcitability. Proceedings of the 11th Wold Congress on Pain, IASP Press 2006:179-86.
  18. Del Tacca M, Colucci R, Fornai M, Blandizzi C. Efficacy and tolerability of meloxicam, COX-2 preferential nonsteroidal anti-inflammatory drug. Clin Drug Invest 2002;22:799-818.
  19. Алексеев В.В. Применение мелоксикама в лечении люмбоишиалгического синдрома // РМЖ 2003. Т. 11. № 7 (179). С. 416-18.
  20. Bosch HC, Sigmund R, Hettich M. Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: a comparison with intramuscular and oral piroxicam. Cur Med Res Opinion 1997;14(1):29-38.
  21. Colberg K, Hettich M, Sigmund R, et al. Efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: a comparison with intramuscular and oral diclofenac in patient with acute lumbago. Cur Med Res Opinion 1996;13(7):363-77.
  22. Müller N, Schwarz MJ, Dehning S, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Molecular Psychiatry 2006;11:680-84.
  23. Renner B, Zacher J, Buvanendran A, et al. Absorption and distribution of etoricoxib in plasma, CSF and wound tissue in patients following hip surgery - a pilot study. J Naunyn-Schmiedeberg Archives Pharmacol. Manuscript ID: Naunyn-00094-2009-R1.
  24. Loeser JD, Melzack R. Pain: an overview. Lancet 1999;353:1607-609
  25. Treede RD, Klein T, Mageri W. Pain Memory and Central Sensitization in Humans. Proceedings of the 11th Wold Congress on Pain. IASP Press 2006:251-67.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies